Safety, tolerability and pharmacokinetics of lorcaserin + phentermine

Trial Profile

Safety, tolerability and pharmacokinetics of lorcaserin + phentermine

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Nov 2013

At a glance

  • Drugs Lorcaserin (Primary) ; Phentermine
  • Indications Obesity
  • Focus Adverse reactions
  • Sponsors Arena Pharmaceuticals
  • Most Recent Events

    • 08 Nov 2013 Status changed from active, no longer recruiting to completed, as reported in an Arena Pharmaceuticals media release.
    • 11 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top